Greenfield L J, Peyton R, Crute S, Barnes R
Arch Surg. 1981 Nov;116(11):1451-6. doi: 10.1001/archsurg.1981.01380230065010.
In a review of clinical experience with the Greenfield filter in 156 patients, the most common indication for insertion was a contraindication to anticoagulation or recurrent embolism during treatment. Most of the filters (86%) were placed infrarenal, with 7% placed intentionally suprarenal and 7% misplaced but amenable to retrieval. Recurrent embolism was suspected in three patients (2%) on the basis of symptoms and was diagnosed by scan in three patients (2%). Follow-up studies on 119 local patients (11 were lost, 49 died) extended to 63 months (average, 23 months) and showed no migration or deaths due to recurrent embolism. Of 102 venacavograms obtained, occlusion of the cava was seen in only three patients (5%), for a long-term patency rate of 95%.
在一项对156例患者使用格林菲尔德滤器的临床经验回顾中,置入滤器最常见的指征是抗凝治疗的禁忌证或治疗期间的反复栓塞。大多数滤器(86%)放置在肾下,7%有意放置在肾上,7%放置错误但可取出。根据症状怀疑3例患者(2%)有反复栓塞,3例患者(2%)经扫描确诊。对119例本地患者的随访研究(11例失访,49例死亡)长达63个月(平均23个月),未发现因反复栓塞导致的移位或死亡。在获得的102份腔静脉造影中,仅3例患者(5%)出现腔静脉闭塞,长期通畅率为95%。